Improved Escherichia coli Bactofection and Cytotoxicity by Heterologous Expression of Bacteriophage ΦX174 Lysis Gene E

• Published in: Molecular pharmaceutics 2015-05, Vol.12 (5), p.1691-1700
• Main Authors: Chung, Tai-Chun, Jones, Charles H, Gollakota, Akhila, Kamal Ahmadi, Mahmoud, Rane, Snehal, Zhang, Guojian, Pfeifer, Blaine A
• Format: Article
• Language: English
• Subjects: Animals; Bacteriophages - metabolism; Cell Line; Escherichia coli; Escherichia coli - genetics; Genetic Therapy; Genetic Vectors - genetics; Mice
• ISSN: 1543-8384; 1543-8392
• DOI: 10.1021/acs.molpharmaceut.5b00172

Bactofection offers a gene delivery option particularly useful in the context of immune modulation. The bacterial host naturally attracts recognition and cellular uptake by antigen presenting cells (APCs) as the initial step in triggering an immune response. Moreover, depending on the bacterial vector, molecular biology tools are available to influence and/or overcome additional steps and barriers to effective antigen presentation. In this work, molecular engineering was applied using Escherichia coli as a bactofection vector. In particular, the bacteriophage ΦX174 lysis E (LyE) gene was designed for variable expression across strains containing different levels of lysteriolysin O (LLO). The objective was to generate a bacterial vector with improved attenuation and delivery characteristics. The resulting strains exhibited enhanced gene and protein release and inducible cellular death. In addition, the new vectors demonstrated improved gene delivery and cytotoxicity profiles to RAW264.7 macrophage APCs.